Impaired cerebral oxygenation and exercise tolerance in patients with severe obstructive sleep apnoea syndrome

M. MARILLIER (Grenoble, France), M. Gruet (Grenoble, France), S. Baillieul (Grenoble, France), B. Wuyam (Grenoble, France), R. Tamisier (Grenoble, France), P. Levy (Grenoble, France), J. Pepin (Grenoble, France), S. Verges (Grenoble, France)

Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Session: Mechanisms that underlie exercise limitation in various respiratory diseases
Session type: Oral Presentation
Number: 480
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. MARILLIER (Grenoble, France), M. Gruet (Grenoble, France), S. Baillieul (Grenoble, France), B. Wuyam (Grenoble, France), R. Tamisier (Grenoble, France), P. Levy (Grenoble, France), J. Pepin (Grenoble, France), S. Verges (Grenoble, France). Impaired cerebral oxygenation and exercise tolerance in patients with severe obstructive sleep apnoea syndrome. 480

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

Cardiopulmonary exercise response in children with obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012


Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009


Myocardial alterations in asymptomatic patients with obstructive sleep apnea syndrome
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017


Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

Inspiratory muscle dysfunction in patients with severe obstructive sleep apnoea
Source: Eur Respir J 2010; 35: 373-380
Year: 2010



Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002

Vasoconstriction during the night in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 419s
Year: 2006

Sympathetic activity at rest and during exercise in metabolic syndrome subjects with and without obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008

Metabolic syndrome in moderate to severe obstructive sleep apnea?
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006

Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006

Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009


Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008

Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


Respiratory muscle function in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 419s
Year: 2001